Bei Zhou

2.7k total citations · 1 hit paper
68 papers, 1.9k citations indexed

About

Bei Zhou is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Bei Zhou has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Rheumatology and 13 papers in Molecular Biology. Recurrent topics in Bei Zhou's work include Psoriasis: Treatment and Pathogenesis (11 papers), Spondyloarthritis Studies and Treatments (9 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). Bei Zhou is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Spondyloarthritis Studies and Treatments (9 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). Bei Zhou collaborates with scholars based in China, United States and United Kingdom. Bei Zhou's co-authors include Alexa P. Kollmeier, Xie L. Xu, Elizabeth C. Hsia, Shihong Sheng, Prasheen Agarwal, Philip Helliwell, Atul Deodhar, Yanli Zhuang, Ramanand A. Subramanian and Christopher T. Ritchlin and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Bei Zhou

65 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

2020 233 citations Atul Deodhar, Philip Helliwell et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bei Zhou China	22	773	722	425	330	208	68	1.9k
Su‐Jin Moon South Korea	28	729 0.9×	566 0.8×	740 1.7×	169 0.5×	110 0.5×	87	2.0k
Keisuke Hagihara Japan	21	352 0.5×	540 0.7×	561 1.3×	274 0.8×	144 0.7×	56	2.0k
Chien‐Hsiun Chen Taiwan	16	262 0.3×	531 0.7×	541 1.3×	94 0.3×	136 0.7×	23	2.3k
Yan Chang China	29	624 0.8×	550 0.8×	762 1.8×	93 0.3×	64 0.3×	66	1.9k
Tiago Torres Portugal	31	1.5k 2.0×	488 0.7×	260 0.6×	201 0.6×	1.4k 6.9×	179	2.8k
Jonathan S. Jaffe United States	18	475 0.6×	198 0.3×	391 0.9×	127 0.4×	49 0.2×	36	1.7k
Jennifer Clay Cather United States	25	1.8k 2.4×	419 0.6×	269 0.6×	225 0.7×	1.3k 6.1×	71	2.6k
M. J. Mitchinson United Kingdom	28	817 1.1×	653 0.9×	518 1.2×	108 0.3×	64 0.3×	72	3.2k
M.W. Greaves United Kingdom	31	941 1.2×	1.2k 1.6×	383 0.9×	159 0.5×	860 4.1×	131	3.1k
Masataka Kohno Japan	22	542 0.7×	357 0.5×	1.2k 2.8×	121 0.4×	25 0.1×	79	2.3k

Countries citing papers authored by Bei Zhou

Since Specialization

Citations

This map shows the geographic impact of Bei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Zhou more than expected).

Fields of papers citing papers by Bei Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Zhou. The network helps show where Bei Zhou may publish in the future.

Co-authorship network of co-authors of Bei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Zhou. A scholar is included among the top collaborators of Bei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Zhou. Bei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mease, Philip J., Christopher T. Ritchlin, Laura C. Coates, et al.. (2025). Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study. Annals of the Rheumatic Diseases. 84(12). 1983–1994.

Li, Jun, et al.. (2024). Application of Perioperative Pain Management in the Perioperative Nursing of Labia Minora Plasty and its Effect on the Rehabilitation of Patients.. PubMed. 30(4). 118–123.

Taylor, Peter C., Georg Schett, T. Huizinga, et al.. (2024). Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study. RMD Open. 10(2). e004278–e004278. 10 indexed citations

Zhang, Yang, et al.. (2023). Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study. Frontiers in Endocrinology. 14. 1184190–1184190. 19 indexed citations

Wang, Anqi, Bei Zhou, Yue Zhu, et al.. (2022). Melatonin Reduces Apoptosis Resistance of Hepatocellular Carcinoma Cells by Inhibiting BMAL1. Integrative Cancer Therapies. 21.

Chen, Qingsong, Yunlin Chen, Fang Qin, et al.. (2022). Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation. Frontiers in Cardiovascular Medicine. 9. 870203–870203. 3 indexed citations

Wang, Miao, et al.. (2021). New Cassane Diterpenoids from the Seed Kernels of Caesalpinia cucullata, Exhibit Anti‐inflammatory Effect in vitro by Inhibiting iNOS Enzymatic Activity. Chinese Journal of Chemistry. 39(6). 1625–1634. 13 indexed citations

Ritchlin, Christopher T., Philip Helliwell, Wolf‐Henning Boehncke, et al.. (2021). Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced. RMD Open. 7(1). e001457–e001457. 50 indexed citations

Han, Xinjia, Zheng Zheng, Bei Zhou, et al.. (2021). Stimulation of α7 Nicotinic Acetylcholine Receptor by Nicotine Suppresses Decidual M1 Macrophage Polarization Against Inflammation in Lipopolysaccharide-Induced Preeclampsia-Like Mouse Model. Frontiers in Immunology. 12. 642071–642071. 28 indexed citations

10.

Mease, Philip J., Philip Helliwell, Dafna D. Gladman, et al.. (2021). Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies. The Lancet Rheumatology. 3(10). e715–e723. 61 indexed citations

11.

McInnes, Iain B., Proton Rahman, Alice B. Gottlieb, et al.. (2020). Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis. Arthritis & Rheumatology. 73(4). 604–616. 56 indexed citations

12.

Zhou, Bei, et al.. (2020). Effect of nicotine on placental inflammation and apoptosis in preeclampsia-like model. Life Sciences. 261. 118314–118314. 11 indexed citations

13.

Cui, Jie, Jiatao Liu, Lulu Fan, et al.. (2020). A zinc finger family protein, ZNF263, promotes hepatocellular carcinoma resistance to apoptosis via activation of ER stress-dependent autophagy. Translational Oncology. 13(12). 100851–100851. 28 indexed citations

14.

Zhou, Bei, Qianqian Lu, Jiatao Liu, et al.. (2019). Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway. International Journal of Biological Sciences. 15(9). 1905–1920. 63 indexed citations

15.

Kollmeier, Alexa P., Elliot S. Barnathan, Christopher O’Brien, et al.. (2018). A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma. Annals of Allergy Asthma & Immunology. 121(5). 568–574. 16 indexed citations

16.

Vollenhoven, Ronald van, Bevra H. Hahn, George C. Tsokos, et al.. (2018). Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study. The Lancet. 392(10155). 1330–1339. 233 indexed citations

17.

Chen, Ling, Jingyun Li, Qian Li, et al.. (2017). Non-Coding RNAs: The New Insight on Hypertrophic Scar. Journal of Cellular Biochemistry. 118(8). 1965–1968. 44 indexed citations

18.

Li, Yifan, Rong Li, Lei Wang, et al.. (2015). Cordycepin induces apoptosis and autophagy in human neuroblastoma SK-N-SH and BE(2)-M17 cells. Oncology Letters. 9(6). 2541–2547. 28 indexed citations

19.

Kollmeier, Alexa P., Bin Chen, Paul J. Dunford, et al.. (2014). The Histamine H4 Receptor Antagonist, JNJ 39758979, Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects. Journal of Pharmacology and Experimental Therapeutics. 350(1). 181–187. 69 indexed citations

20.

Hu, Bing, Lin Wang, Bei Zhou, et al.. (2009). Efficient procedure for isolating methylated catechins from green tea and effective simultaneous analysis of ten catechins, three purine alkaloids, and gallic acid in tea by high-performance liquid chromatography with diode array detection. Journal of Chromatography A. 1216(15). 3223–3231. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact